Sharekhan's research report on Vinati Organics
Company had a strong FY25 with Revenue/PAT growth of 18%/26% respectively after a decline in FY24. ATBS and Antioxidants registered a strong 30%/70% revenue growth in FY25. The management expects a 20% revenue growth for the next three years led mainly by ATBS and Antioxidants (AOs), with long term sustainable blended EBITDA margin of 26-27%.
Outlook
We maintain a Buy on the stock, assigning a multiple of 40x on its FY27 EPS and arrive at a TP of Rs. 2,300, The stock is trading at 43x/34x its FY26/27 EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
